Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06934577 · ClinicalTrials.gov registry record · NA
Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2
A NA study of Glaucoma and Eye Diseases, sponsored by University of Michigan.
- Recruiting
- Registry status
- NA
- Development phase
- 900
- Enrollment target
- 1
- Study location
NCT06934577: Recruiting NA study of Glaucoma and Eye Diseases, sponsored by University of Michigan.
NCT06934577 is a NA study of Glaucoma and Eye Diseases that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 900 participants, roughly in line with the 901-participant average among 92 other Glaucoma trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06934577, a NA study of Glaucoma and Eye Diseases, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- NA
- Development phase
- 900 participants
- Enrollment target
- 1
- Study location
Study Summary
To compare eye disease detection rates at a Federally Qualified Health Center between a technology-enhanced protocol and standard optometric clinical examination for three of the leading causes of blindness: glaucoma, diabetic retinopathy, and visually significant cataract.
Conditions Studied
Interventions
- OTHER Standard optometric examination
- OTHER Technology enhanced eye disease detection protocol
Study Locations (1)
Michigan
- Hamilton Optometry Clinic - Flint
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 2025-12-04 |
| Est. Completion | 2030-08 |
| Phase | NA |
What NCT06934577 shows while recruiting
NCT06934577 is an interventional study that assigns participants to a tested intervention. The registered 900 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 901-participant average among 92 other Glaucoma trials with a reported enrollment target.
The record links to 3 conditions, with Glaucoma appearing as the primary indexed condition, and to 2 interventions - of which Standard optometric examination is the first listed.
NCT06934577 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT06934577 about?
NCT06934577 is a clinical study titled "Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2". To compare eye disease detection rates at a Federally Qualified Health Center between a technology-enhanced protocol and standard optometric clinical examination for three of the leading causes of blindness: glaucoma, diabetic retinopathy, and visually significant cataract.
What is the current status of trial NCT06934577?
This trial is currently recruiting. It is a NA study. The enrollment target is 900 participants. The study started on 2025-12-04. Estimated completion is 2030-08.
What conditions does trial NCT06934577 study?
This clinical trial studies the following conditions: Glaucoma, Eye Diseases, Visual Impairment.
What interventions are being tested in trial NCT06934577?
The interventions under investigation include: Standard optometric examination (OTHER), Technology enhanced eye disease detection protocol (OTHER).
Who is sponsoring clinical trial NCT06934577?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06934577 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06934577's enrollment target sits among peer trials
900 6th of 92 higher than 87 of 92 other Glaucoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Glaucoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Tolerability of an Anesthesia-free Tonometer Tip
RECRUITING · NA
-
Electrical Stimulation for the Treatment of Optic Neuropathies
RECRUITING · NA
-
The Role of Music in Enhancing Attention During Visual Field Exams for Pediatric Glaucoma Patients
RECRUITING · NA
-
Electrical Stimulation for the Treatment of Glaucoma
RECRUITING · NA
-
Hyperbaric Oxygen Therapy for Optic Neuropathies
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02352116 · 900 participants · NA
Evaluation of Post-PACU Pain Management in Pediatric Surgery
- NCT02414347 · 900 participants
F 18 T807 Tau PET Imaging of Alzheimer's Disease
- NCT02670408 · 900 participants
Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation
- NCT02960022 · 900 participants · Phase 2
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI